References
- Borden E C. Interferons: Pleiotropic cellular modulators. Clin Immunol Immunopathol 1992; 62: S18–S24
- Vilcek J, Gresser I, Merigan T C. Regulatory functions of interferons. Ann NY Acad Sci 1980; 350: 1–129
- Brouty-Boye D, Zetter B R. Inhibition of cell motility by interferon. Science 1980; 208: 516–518
- Revel M. Host defense against infections and inflammations: Role of the multifunctional IL-6/IFN-β2 cytokine. Experientia 1989; 45: 549–557
- Pace J L, Russell S W, Torres B A, Johnson H M, Gray P W. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 1983; 130: 2011–2013
- Sidky Y A, Borden E C. Inhibition of angiogenesis by interferons: Effects on tumor-and lymphocyte-induced vascular responses. Cancer Res 1987; 47: 5155–5161
- Ezekowitz R AB, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. New Engl J Med 1992; 326: 1456–1463
- BenEzra D. Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am J Ophthalmol 1978; 86: 455–461
- BenEzra D, Hemo I, Maftzir G. In vivo angiogenic activity of interleukins. Arch Ophthalmol 1990; 108: 573–576
- Balkwill F R, Moodie E M, Greedman V, Fantes K H. Human interferons inhibit the growth of established human breast tumors in the nude mouse. Int J Cancer 1982; 30: 231–235
- Sidky Y A, Borden E C, Wierenga W, Bryan G T. Inhibitory effects of interferon-inducing pyrimidinones on the growth of transplantable mouse bladder tumors. Cancer Res 1986; 46: 3798–3802
- Merigan T C. Human interferon as a therapeutic agent: a decade passes. N Engl J Med 1988; 318: 1458–1460
- Groopman J E, Gottlieb M S, Goodman J. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 671–676
- Rios A, Mansell P W, Newell G R, Reuben J M, Hersh E M, Gutterman J U. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma with lymphoblastoid interferon. J Clin Oncol 1985; 3: 506–512
- White C W, Sondheimer H M, Crouch E C, Wilson H, Fan L L. Treatment of pulmonary hemangiomatosis with recombinant interferon α-2a. N Engl J Med 1989; 320: 1197–1200
- Orchard P J, Smith C M, Woods W G, Day D L, Dehner L P, Shapiro R. Treatment of haemangioendotheliomas with α-interferon. Lancet 1989; 2: 565–567
- White C W, Wolf S J, Korones D N, Sondheimer H M, Tosi M F, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon α-2a. J Pediatr 1991; 118: 59–66